EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study

Verbleib in telehealth-gestützter Buprenorphin-Behandlung bei Opioidgebrauchsstörung: multistaatliche retrospektive Kohortenstudie

Laura B Monico iD, Elizabeth A Bambury iD, Jennifer K Foreman iD, Melody Avila iD, Stephen A Martin iD

Journal of Medical Internet Research · 14.08.2026 · 28 · e100527-e100527

DOI: 10.2196/100527 ↗

Auf einen Blick

In einer telehealth-only-Kohorte blieb ein großer Teil der Patient:innen über 24 Monate in Behandlung. Die Retention war bei vorheriger Buprenorphin-Exposition höher als ohne Vorbehandlung.

Fragestellung

Wie hoch ist die Retention in einem telehealth-gestützten Buprenorphin-Programm über 24 Monate, insgesamt und nach Behandlungsweg?

Methode

Retrospektive Kohortenstudie mit Erwachsenen in einem multistaatlichen telehealth-only-Programm; Einschluss zwischen 1. Mai 2019 und 30. April 2025.

Ergebnisse

22.064 Patient:innen. Retention: 86,8 % nach 1 Monat, 71,0 % nach 6 Monaten und danach rückläufig bis 24 Monate. Bei Vorbehandlung war die Retention nach 6 Monaten höher: 70,4 % vs. 52,0 %; Risikodifferenz 18,5 Prozentpunkte (95 %-KI 15,5–21,5).

Schlussfolgerung der Autor:innen

In dieser großen multistaatlichen Studie war die Retention unter telehealth-only-Buprenorphinbehandlung vergleichbar mit oder deutlich höher als nationale Benchmarks.

Kernaussagen

  • Retention sank von 86,8 % nach 1 Monat auf 71,0 % nach 6 Monaten.
  • Vorherige Buprenorphin-Exposition war mit höherer Retention verbunden.
  • Der höchste frühe Wert wurde im High-Dose-Pfad gesehen.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 14.08.2026. Verfasst von Laura B Monico und 4 weiteren Autor:innen. Beteiligte Einrichtung: Boulder Care, 111 SW Naito Parkway, Suite 200, Portland, OR, 97204, United States, 1 (503) 208-5061. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders, Telemedicine, Opiate Substitution Treatment. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Buprenorphine is an effective treatment for opioid use disorder and is associated with reduced mortality when retention is high; however, national studies show low retention. Evidence from outpatient settings, including telehealth, remains limited, despite population-level analyses suggesting improved retention with virtual care. Further research is needed to better understand retention and optimize care for people with opioid use disorder.

Objective

This study aimed to describe patient retention in a telehealth-delivered buprenorphine program over 24 months, both overall and by treatment transition pathway.

Methods

We conducted a retrospective cohort study of adults initiating opioid use disorder treatment in a multistate, telehealth-only addiction treatment program between May 1, 2019, and April 30, 2025. Before March 2020, participants completed an in-person visit before transitioning to telehealth. Participants completed an intake appointment and either continued on a stable dose of buprenorphine started prior to care entry or transitioned to buprenorphine treatment via 1 of 6 treatment pathways (high dose, standard low dose, standard, Quick Start, low dose, or other). Retention in care was defined by ongoing clinical engagement, specifically through a completed medical visit or a patient-initiated secure message, each of which was required to continue buprenorphine treatment. Retention was analyzed both overall and by patient characteristics and treatment pathway. Chi-square tests and absolute risk differences with 95% CIs were used for comparisons.

Results

Among 22,064 patients, the mean age was 41.2 (SD 9.9) years, 48.6% (10,542/21,676) were female, 33.8% (7464/22,064) lived in rural areas, 78.5% (16,826/21,446) were enrolled in Medicaid, and 37.1% (8181/22,064) transitioned to buprenorphine. Retention declined from 86.8% (19,154/22,064) at month 1 to 71.0% (11,488/16,183) at month 6 and then declined gradually through 24 months. At month 6, retention was higher among patients with prior buprenorphine exposure (8613/12,230, 70.4% vs 586/1128, 52.0%; risk difference: 18.5 percentage points, 95% CI 15.5%‐21.5%). Retention varied by pathway, with high dose showing the highest early retention (2330/2870, 81.2% at month 1), while patients already receiving buprenorphine at intake had higher retention than all other transition pathways.

Conclusions

In this large, multistate study of telehealth-only buprenorphine treatment, retention was comparable to or markedly higher than national benchmarks. These findings underscore the potential of low-threshold, harm-reduction telehealth models to support long-term retention in opioid use disorder care during a period in which illicitly manufactured fentanyl predominates in the drug supply.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineOpioid-Related DisordersTelemedicineOpiate Substitution TreatmentRetention in CareHumansRetrospective StudiesFemaleAdultMaleMiddle Aged

Stichwörter der Autor:innen

OUDMOUDbuprenorphinemedications for opioid use disorderopioid use disorderretention in treatmenttelehealthvirtual care

Substanzen

Buprenorphine

Autor:innen und Institutionen

  • Boulder Care, 111 SW Naito Parkway, Suite 200, Portland, OR, 97204, United States, 1 (503) 208-5061.
  • Department of Family Medicine and Community Health, University of Massachusetts Chan Medical School, Worcester, MA, United States.

ORCID-Profile: Laura B Monico, Elizabeth A Bambury, Jennifer K Foreman, Melody Avila, Stephen A Martin

Zitieren

APA

Monico, L. B., Bambury, E. A., Foreman, J. K., Avila, M., & Martin, S. A. (2026). Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study. Journal of Medical Internet Research, 28, e100527-e100527. https://doi.org/10.2196/100527

Vancouver

Monico LB, Bambury EA, Foreman JK, Avila M, Martin SA. Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study. Journal of Medical Internet Research. 2026;28:e100527-e100527. doi:10.2196/100527

BibTeX
@article{Monico2026,
  author = {Monico, Laura B and Bambury, Elizabeth A and Foreman, Jennifer K and Avila, Melody and Martin, Stephen A},
  title = {Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e100527--e100527},
  doi = {10.2196/100527}
}
Kostenlos starten →